Investor's Business Daily on MSN15h
Edwards Makes A Bullish Move As Heart-Valve Replacements Top $1 BillionEdwards Lifesciences stock popped Wednesday on strong sales of its TAVR procedures, leading to a top- and bottom-line beat.
As tools become more precise and non-invasive, doctors are able to diagnose and treat heart conditions with greater accuracy and efficiency.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback